Peri-interventional coronary vasomotion

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 4, 2012, Pages 883-889

  Gregorini, Luisa ^a   Marco, Jean ^b   Heusch, Gerd ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b CLINIQUE PASTEUR   (France)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Alpha adrenoceptors; Microcirculation; No reflow; Percutaneous coronary intervention; Slow flow; Sympathetic nervous system; Urapidil

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; BETA ADRENERGIC RECEPTOR; DILTIAZEM; HEPARIN; NITROPRUSSIDE SODIUM; PHENTOLAMINE; PROPRANOLOL; TICLOPIDINE; URAPIDIL; VERAPAMIL; YOHIMBINE;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY FLOW RESERVE; CORONARY STENT; CORONARY VASCULAR RESISTANCE; HEART LEFT VENTRICLE FUNCTION; HUMAN; NO REFLOW PHENOMENON; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; VASOMOTOR REFLEX;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY CIRCULATION; HUMANS; NO-REFLOW PHENOMENON; SYMPATHETIC NERVOUS SYSTEM;

ANGINA;

EID: 84858284456     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.09.017     Document Type: Review

References (56)

1. Bassenge E., Heusch G. Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol 1990, 116:77-165.
2. Rosendorff C., Hoffman J.I.E., Verrier E.D., Rouleau J., Boerboom L.E. Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs. Circ Res 1981, 48:320-329.
3. Heusch G. The paradox of α-adrenergic coronary vasoconstriction revisited. J Mol Cell Cardiol 2011, 51:16-23.
4. Heusch G. Alpha-adrenergic mechanisms in myocardial ischemia. Circulation 1990, 81:1-13.
5. Heusch G., Deussen A. The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res 1983, 53:8-15.
6. Chilian W.M. Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation. Circulation 1991, 84:2108-2122.
7. Malliani A., Schwartz P.J., Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 1969, 217:703-709.
8. Heusch G., Deussen A., Thämer V. Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feedback aggravation of myocardial ischemia. J Auton Nerv Syst 1985, 13:311-326.
9. Baumgart D., Heusch G. Neuronal control of coronary blood flow. Basic Res Cardiol 1995, 90:142-159.
10. Feigl E.O. Neural control of coronary blood flow. J Vasc Res 1998, 35:85-92.
11. Nakane T., Tsujimoto G., Hashimoto K., Chiba S. Beta adrenoceptors in the canine large coronary arteries: beta-1 adrenoceptors predominate in vasodilation. J Pharmacol Exp Ther 1988, 245:936-943.
12. Murphree S.S., Saffitz J.E. Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium. Circ Res 1988, 63:117-125.
13. Barbato E., Piscione F., Bartunek J., Galasso G., Cirillo P., De Luca G., Iaccarino G., De Bruyne B., Chiariello M., Wijns W. Role of β-2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation 2005, 111:288-294.
14. Gregorini L., Fajadet J., Robert G., Cassagneau B., Bernis M., Marco J. Coronary vasoconstriction following percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation 1994, 90:805-907.
15. Gregorini L., Marco J., Palombo C., Kozáková M., Anguissola G.B., Cassagneau B., Bernies M., Distante A., Marco I., Fajadet J., Zanchetti A. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents. J Am Coll Cardiol 1998, 31:992-1001.
16. Gregorini L., Marco J., Kozàkovà M., Palombo C., Anguissola G.B., Marco I., Bernies M., Cassagneau B., Distante A., Bossi I.M., Fajadet J., Heusch G. α -Adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999, 99:482-490.
17. 2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 2002, 106:2901-2907.
18. Fischell T.A., Derby G., Tse T.M., Stadius M.L. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty: a quantitative arteriographic analysis. Circulation 1988, 78:1323-1334.
19. Gibson M.C., Ryan K.A., Murphy S.A., Masley R., Marble S.J., Giugliano R.P., Cannon C.P., Antman E.M., Braunwald E. For the TIMI Study Group. Impaired coronary blood flow in non culprit arteries in the setting of acute myocardial infarction. J Am Coll Cardiol 1999, 34:974-982.
20. Macaya C., Alfonso F., Iniguez A., Coicolea J., Hernandez R., Zarco P. Stenting for elastic recoil during coronary angioplasty of the left main coronary artery. Am J Cardiol 1992, 70:105-110.
21. Haude M., Erbel R., Issa H., Meyer J. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon expandable Palmaz-Schatz stents. J Am Coll Cardiol 1993, 21:26-34.
22. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M., Cleman M., Heuser R., Almond D., Teirstein P.S., Fish D., Colombo A., Brinker J., Moses J., Shaknovich A., Hirshfeld S., Bailey S., Ellis S., Rake R., Goldberg S. For the Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. New Engl. J Med 1994, 331:496-501.
23. Kern M.J., Puri S., Bach R.G., Donohue T.J., Dupouy P., Caracciolo E.A., Craig W.R., Aguirre F., Aptecar E., Wolford T.L., Mechem C.J., Dubois-Rande J.L. Abnormal coronary flow velocity reserve after coronary artery stenting in patients. Role of relative coronary reserve to assess potential mechanisms. Circulation 1999, 100:2491-2498.
24. Heusch G. Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve. Basic Res Cardiol 2010, 105:1-5.
25. Balagny D., Gauzit R., Marty J., Couderc E., Levron J.C., Desmonts J.M. Effects of droperidol on sympathetic activity and baroreflex control of heart rate in humans. Anesthesiology 1987, 67:473-476.
26. van Nueten J.M., Reneman R.S., Janssen P.A. Specific alpha-adrenoceptor blocking effect of droperidol on isolated smooth muscles. Eur J Pharmacol 1977, 44:1-8.
27. Baumgart D., Haude M., Gorge G., Liu F., Ge J., Große-Eggebrecht C., Erbel R., Heusch G. Augmented α-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999, 99:2090-2097.
28. Maes A., Van de Werf F., Nuyts J., Bormans G., Desmet W., Mortelmans L. Impaired myocardial tissue perfusion early after successful thrombolysis: impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995, 92:2072-2078.
29. Kim C.B., Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 1993, 88:2426-2436.
30. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T., Alexander B., Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996, 93:879-888.
31. Krumholz H.M., Wang Y., Chen J., Drye E.E., Spertus J.A., Ross J.S., Curtis J.P., Nallamothu J.P., Lichtman J.H., Havranek E.P., Massoudi F.A., Radford M.J., Han L.F., Rapp M.T., Straube B.M., Normand S-LT. Reduction in acute myocardial infarction mortality in the United States: Risk-standardized mortality rates from 1995-2006. JAMA 2009, 302:767-773.
32. Kloner R.A., Ganote C.E., Jennings R.B. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974, 54:1496-1508.
33. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985, 71:699-708.
34. Schofer J., Montz R., Mathey D. Scintigraphic evidence of the 'no-reflow' phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985, 5:593-598.
35. Wilson R.F., Lesser J.R., Laxon D.D., White S.W. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989, 1:807-811.
36. Jeremy R.W., Links J.M., Becker L.C. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol 1990, 16:695-704.
37. Topol E.J., Yadav S.J. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000, 101:570-580.
38. Erbel R., Heusch G. Coronary microembolization. J Am Coll Cardiol 2000, 36:22-24.
39. Rezkalla S.H., Kloner R.A. No-reflow phenomenon. Circulation 2002, 105:656-662.
40. Skyschally A., Leineweber K., Gres P., Haude M., Erbel R., et al. Coronary microembolization. Basic Res Cardiol 2006, 101:359-372.
41. Heusch G., Kleinbongard P., Böse D., Levkau B., Haude M., Schulz R., Erbel R. Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009, 120:1822-1836.
42. Bekkers S.C.A.M., Yazdani S.K., Virmani R., Waltenberger J. Microvascular obstruction. Underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol 2010, 55:1649-1660.
43. Kleinbongard P., Böse D., Baars T., Möhlenkamp S., Konorza T., Schöner S., Elter-Schulz M., Eggebrecht H., Degen H., Haude M., Levkau B., Schulz R., Erbel R., Heusch G. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res 2011, 108:344-352.
44. Thielmann M., Massoudy P., Schmermund A., Neuhäuser M., Marggraf G., Kamler M., Herold U., Aleksic I., Mann K., Haude M., Heusch G., Erbel R., Jakob H. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 2005, 26:2440-2447.
45. Roach G.W., Kanchuger M., Mora Mangano C.T., Newman M.F., Nussmeier N.A., Wolman R., Aggarwal A., Marschall K., Graham S.H., Ley C., Ozanne G., Mangano D.T. for the multicenter coronary bypass surgery study of perioperative ischemia (McSPI) research group and education foundation investigators. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996, 335:1857-1863.
46. Sato H., Iida A., Tanaka H., Tanaka S., Shimodouzono E., Uchida T., Kawarabayashi, Yoshikawa A. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. J Am Coll Cardiol 2004, 44:300-304.
47. Boese D., von Birgelen C., Zhou X.Y., Schmermund A., Philipp S., Sack S., Konorza T., Mohlenkamp S., Leineweber K., Kleinbongard P., Wijns W., Heusch G., Erbel R. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol 2008, 103:587-597.
48. Kaplan B.M., Benzuly K.H., Kinn J.W., Bowers T.R., Tilli F.V., Grines C.L., O'Neill W.W., Safian R.D. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn 1996, 39:113-118.
49. Fugit M.D., Rubal B.J., Donovan D.J. Effects of intracoronary nicardipine, diltiazem, and verapamil on coronary blood flow. J Invasive Cardiol 2000, 12:80-85.
50. Eeckhout E., Kern M.J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001, 22:729-739.
51. Hillegass W.B., Dean N.A., Liao L., Rhinehart R.G., Myers P.R. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001, 37:1335-1343.
52. Parham W.A., Bouhasin A., Ciaramita J.P., Khoukaz S., Herrmann S.C., Kern M.J. Coronary hyperemic dose responses of intracoronary sodium nitroprusside. Circulation 2004, 109:1236-1243.
53. Neumann F.J., Blasini R., Schmitt C., Alt E., Dirschinger J., Gawaz M., Kastrati A., Schömig A. Effect of glycoprotein IIb/IIIa receptor blockade or of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998, 98:2695-2701.
54. Desmet W., Bogaert J., Dubois C., Sinnaeve P., Adriaenssens T., Pappas C., Ganame G., Dymarkowsky S., Janssens S., Belmans A., Van de Werf F. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 2011, 32:867-877.
55. Gregorini L., Marco J., Bernies M., Cassagneau B., Pomidossi G., Anguissola G.B., Fajadet J. The alpha-1 adrenergic blocking agent urapidil counteracts postrotational atherectomy "elastic recoil" where nitrates have failed. Am J Cardiol 1997, 15;79(8):1100-1103.
56. Heusch G., Baumgart D., Camici P., Chilian W., Gregorini L., Hess O., Indolfi C., Rimoldi O. α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 2000, 101:689-694.